Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Disposable Masks Manufacturer Looks To Future Growth

Executive Summary

Consumer demand for masks likely won’t slow following the pandemic, says DemeTECH VP Luis Arguello Jr. The PPE and medical equipment company has continued manufacturing masks despite supply chain disruptions and increased competition.

You may also be interested in...



Sens. Baldwin And Cassidy Want Medical Devices Made In The USA

US Senators Tammy Baldwin and Bill Cassidy have introduced legislation to ensure frontline workers have the supplies they need for the next health emergency.

Final Guidance From FDA Maintains Relaxed Restrictions On Face Coverings

The US Food and Drug Administration continues to ease up on rules around various types of face protectors and respirators throughout the duration of the COVID-19 pandemic, so long as they do not pose an undue risk to the public health and provide proper labeling.

Certain Chinese-Made Respirators No Longer Authorized By FDA

After CDC concerns about the quality of Chinese-manufactured respirators, the US FDA has pulled a number of products from its list of authorized respirators for health care providers. The agency said the remaining authorized respirators made in China are no longer eligible for use after being decontaminated due to concerns about their ability to hold up after decontamination.

Topics

Related Companies

Latest News
See All
UsernamePublicRestriction

Register

MT144893

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel